The U.S. Food and Drug Administration has updated its guidance for reporting adverse effects of various products, including dietary supplements, during the coronavirus pandemic. The FDA does not consider CBD a dietary supplement. But many CBD manufacturers do and follow FDA guidance on making and selling dietary supplements. The agency made the announcement this month, saying […]
FDA updates reporting requirements for product adverse effects is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
From FDA updates reporting requirements for product adverse effects on CBD Products & CBD Business News – Hemp Industry Daily.
This was autoposted by IFTTT. To find out more, read my post about news articles.
No comments:
Post a Comment